» Articles » PMID: 3539336

A Monoclonal Antibody with Binding and Inhibiting Activity Towards Human Pancreatic Carcinoma Cells. I. Immunohistological and Immunochemical Characterization of a Murine Monoclonal Antibody Selecting for Well Differentiated Adenocarcinomas of The...

Overview
Date 1986 Jan 1
PMID 3539336
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The murine monoclonal antibody (MAb) BW 494 was characterized in relation to its tissue specificity, the epitope recognized, in vitro and in vivo radiolocalization and its potential to mediate antibody dependent cellular cytotoxicity (ADCC) and complement mediated cytolysis (CMC). The MAb defined carbohydrate epitope located on a greater than 200 k daltons glycoprotein was mainly expressed on the majority of well differentiated adenocarcinomas of the pancreas. Furthermore, the epitope is accessible to MAb BW 494 in vivo, allowing an enrichment of radioactive antibody at the tumor site in nude mice. Additionally, MAb BW 494 is able to use human peripheral blood lymphocytes as effector cells for ADCC reactions against appropriate tumor target cells in vitro. In contrast, the antibody does not mediate human or rabbit CMC.

Citing Articles

Pancreatic cancer: a review of emerging therapies.

Rosenberg L Drugs. 2000; 59(5):1071-89.

PMID: 10852640 DOI: 10.2165/00003495-200059050-00004.


Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers.

Friess H, Gassmann M, Buchler M Int J Pancreatol. 1997; 21(1):43-52.

PMID: 9127173 DOI: 10.1007/BF02785919.


Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts.

Kondo Y, Chung Y, Sawada T, Inui A, Yamashita Y, Hirayama K Jpn J Cancer Res. 1995; 86(11):1072-9.

PMID: 8567399 PMC: 5920632. DOI: 10.1111/j.1349-7006.1995.tb03023.x.


In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation.

Joseph K, Hoffken H, Bosslet K, Schorlemmer H Eur J Nucl Med. 1988; 14(7-8):367-73.

PMID: 3181186 DOI: 10.1007/BF00254386.


[Immunohistochemistry in pancreatic cancer with new monoclonal antibodies].

Kubel R, Buchler M, Baczako K, Beger H Langenbecks Arch Chir. 1987; 371(4):243-52.

PMID: 2830443 DOI: 10.1007/BF01258972.


References
1.
Ey P, Prowse S, JENKIN C . Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978; 15(7):429-36. DOI: 10.1016/0161-5890(78)90070-6. View

2.
Schmiegel W, Kalthoff H, Arndt R, Gieseking J, Greten H, Kloppel G . Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res. 1985; 45(3):1402-7. View

3.
Yu R, Ledeen R . Gangliosides of human, bovine, and rabbit plasma. J Lipid Res. 1972; 13(5):680-6. View

4.
Harpin M, COULON-MORELEC M, Yeni P, DANON F, Baumann N . Direct sensitive immunocharacterization of gangliosides on plastic thin-layer plates using peroxidase staining. J Immunol Methods. 1985; 78(1):135-41. DOI: 10.1016/0022-1759(85)90336-9. View

5.
Bosslet K, Luben G, Stark M, Sedlacek H . Molecular characteristics of two lung carcinoma cell-line associated membrane antigens. Behring Inst Mitt. 1984; (74):27-34. View